- $63.51bn
- $66.71bn
- $35.46bn
- 62
- 48
- 98
- 79
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 12.24 | ||
PEG Ratio (f) | 1.43 | ||
EPS Growth (f) | 9.39% | ||
Dividend Yield (f) | 0.65% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.58 | ||
Price to Tang. Book | 2.59 | ||
Price to Free Cashflow | 30.28 | ||
Price to Sales | 1.7 | ||
EV to EBITDA | 9.99 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 18.76% | ||
Return on Equity | 21.52% | ||
Operating Margin | 17.68% |
Financial Summary
Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 17,592.9 | 20,311.1 | 27,774.2 | 33,480 | 35,460.4 | 36,963.97 | 39,413.96 | 17.15% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +2.61 | +47.83 | +81.06 | +44.97 | -15.87 | +4.01 | +9.61 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
D.R. Horton, Inc. is a homebuilding company. The Company is primarily engaged in the acquisition and development of land and the construction and sale of residential homes. Its segments include Homebuilding, Rental, Forestar, Financial Services, and Other. The Company’s Homebuilding segment designs, builds and sells single-family detached homes on lots they develop and on fully developed lots purchased ready for home construction. The Rental segment consists of single-family and multi-family rental operations. The single-family rental operations primarily construct and lease single-family homes within a community and then market each community for a bulk sale of rental homes. The Forestar segment is a residential lot development company. The Financial services segment provides mortgage financing, title agency services and title insurance to homebuyers in many of the Company’s homebuilding markets. In addition, it also conducts insurance-related operations.
Directors
- Donald Horton CHM (71)
- David Auld CEO (65)
- Bill Wheat CFO (55)
- Michael Murray COO (55)
- Paul Romanowski COO (51)
- Barbara Allen IND (75)
- Bradley Anderson IND (60)
- Michael Buchanan IND (74)
- Benjamin Carson IND (70)
- Michael Hewatt IND (72)
- Maribess Miller IND (68)
- Last Annual
- September 30th, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- July 1st, 1991
- Public Since
- June 5th, 1992
- No. of Shareholders
- 265
- No. of Employees
- 13,450
- Sector
- Homebuilding & Construction Supplies
- Industry
- Consumer Cyclicals
- Exchange
- New York Stock Exchange
- Shares in Issue
- 326,040,096
- Address
- 1341 Horton Cir, ARLINGTON, 76011-4310
- Web
- https://www.drhorton.com/
- Phone
- +1 8173908200
- Contact
- Jessica Hansen
- Auditors
- Ernst & Young LLP
Upcoming Events for DHI
Q4 2024 DR Horton Inc Earnings Release
DR Horton Inc Annual Shareholders Meeting
Q1 2025 DR Horton Inc Earnings Release
Similar to DHI
Acuity Brands
New York Stock Exchange
Advanced Drainage Systems
New York Stock Exchange
Armstrong World Industries
New York Stock Exchange
Azek
New York Stock Exchange
Beazer Homes USA
New York Stock Exchange
FAQ
As of Today at 20:48 UTC, shares in DR Horton are trading at $194.80. This share price information is delayed by 15 minutes.
Shares in DR Horton last closed at $194.80 and the price had moved by +69.1% over the past 365 days. In terms of relative price strength the DR Horton share price has outperformed the S&P500 Index by +33.76% over the past year.
The overall consensus recommendation for DR Horton is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe DR Horton dividend yield is 0.59% based on the trailing twelve month period.
Last year, DR Horton paid a total dividend of $1.15, and it currently has a trailing dividend yield of 0.59%. We do not have any data on when DR Horton is to next pay dividends.
We do not have data on when DR Horton is to next pay dividends. The historic dividend yield on DR Horton shares is currently 0.59%.
To buy shares in DR Horton you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $194.80, shares in DR Horton had a market capitalisation of $63.51bn.
Here are the trading details for DR Horton:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: DHI
Based on an overall assessment of its quality, value and momentum DR Horton is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in DR Horton is $188.09. That is 3.44% below the last closing price of $194.80.
Analysts covering DR Horton currently have a consensus Earnings Per Share (EPS) forecast of $14.57 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DR Horton. Over the past six months, its share price has outperformed the S&P500 Index by +17.54%.
As of the last closing price of $194.80, shares in DR Horton were trading +26.51% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The DR Horton PE ratio based on its reported earnings over the past 12 months is 12.24. The shares last closed at $194.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
DR Horton's management team is headed by:
- Donald Horton - CHM
- David Auld - CEO
- Bill Wheat - CFO
- Michael Murray - COO
- Paul Romanowski - COO
- Barbara Allen - IND
- Bradley Anderson - IND
- Michael Buchanan - IND
- Benjamin Carson - IND
- Michael Hewatt - IND
- Maribess Miller - IND